Completed NA INTERVENTIONAL 2-arm NCT02434042

Effects of Bifidobacterium Longum BB536 on Incidence of Acute Diarrhea and/or Respiratory- Related Illnesses in Children

Study on Oral Administration of Bifidobacterium Longum BB536 on Incidence of Acute Diarrhea and/or Respiratory- Related Illnesses Compared to Placebo

Sponsor: Morinaga Milk Industry Co., LTD

Conditions Healthy Volunteers

Interventions BB536 Placebo

Updated 8 times since 2017 Last updated: Nov 2, 2017 Started: Apr 1, 2015 Primary completion: Feb 28, 2016 Completion: Feb 28, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Healthy Volunteers, this trial is completed. The trial is conducted by Morinaga Milk Industry Co., LTD and has accumulated 8 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Aug 2020 — Jan 2021 [monthly]

Completed NA
May 2020 — Aug 2020 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — May 2020 [monthly]

Completed NA
Dec 2017 — Jun 2018 [monthly]

Completed NA

Phase: PHASE2_PHASE3 → NA
Jan 2017 — Dec 2017 [monthly]

Completed PHASE2_PHASE3

First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Morinaga Milk Industry Co., LTD
Universiti Sains Malaysia

Data source: Universiti Sains Malaysia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pulau Pinang, Malaysia